ARTICLE | Distillery Therapeutics
Therapeutics: L selectin (CD62L; SELL)
June 2, 2016 7:00 AM UTC
Mouse studies suggest a subset of natural killer T (NKT) cells engineered to express tumor antigen-specific chimeric antigen receptors (CARs) could help treat cancer. NKT cells expressing CD62L had lo...